APA (7th ed.) Citation

MM, T., J, G., SW, B., S, C., & JA, C. (2026). Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course. British journal of haematology, 208(6), 2311. https://doi.org/10.1111/bjh.70459

Chicago Style (17th ed.) Citation

MM, Thant, Gollamudi J, Benoit SW, Chonat S, and Cancelas JA. "Differential Complement Activation by Alloantibodies in Sickle Cell Hyperhaemolysis Syndrome May Influence Disease Course." British Journal of Haematology 208, no. 6 (2026): 2311. https://doi.org/10.1111/bjh.70459.

MLA (9th ed.) Citation

MM, Thant, et al. "Differential Complement Activation by Alloantibodies in Sickle Cell Hyperhaemolysis Syndrome May Influence Disease Course." British Journal of Haematology, vol. 208, no. 6, 2026, p. 2311, https://doi.org/10.1111/bjh.70459.